Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to:
- Compare the treatment efficacy of autologous mesenchymal stem cells (Mesenchymal Stem Cells) versus chondrocytes implanted in a commercial available scaffold in a human clinical trial.
- Determine the effects of specific three months strength training program preoperatively to improve knee function and possible postpone the need of cartilage repair surgery.
- Determine if degenerative changes occur in the knee joints following cartilage repair. This question will be investigated in the proposed clinical trial.
- Determine the characteristics of patients treated either by surgery or by rehabilitation in a long-term follow-up (1, 5 years).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Apr 2009
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 17, 2009
CompletedFirst Posted
Study publicly available on registry
April 22, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedOctober 15, 2015
October 1, 2015
2.2 years
April 17, 2009
October 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lysholm score
2018
Secondary Outcomes (1)
Radiographics
Two and five years
Other Outcomes (1)
Return to work
1 Year
Study Arms (2)
Stem cells
EXPERIMENTALCartilage defect are treated surgical either with chondrocytes or stem cells
Rehabilitation
ACTIVE COMPARATORActive rehabilitation program
Interventions
Eligibility Criteria
You may qualify if:
- Norwegian citizens
- A full-thickness cartilage lesion (diameter \> 15 mm, but less than 6 cm2 and Lysholm score \< 75 points) located on the femoral condyle
You may not qualify if:
- Patients with malignment of the knee
- Other knee pathology such as ACL injury or a nontreated meniscus injury will not be included in the study to avoid the impact of these knee pathologies on the final results
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oslo UniversityHospital-Ullevaal
Oslo, Oslo County, 0481, Norway
Related Publications (3)
Aroen A, Brogger H, Rotterud JH, Sivertsen EA, Engebretsen L, Risberg MA. Evaluation of focal cartilage lesions of the knee using MRI T2 mapping and delayed Gadolinium Enhanced MRI of Cartilage (dGEMRIC). BMC Musculoskelet Disord. 2016 Feb 11;17:73. doi: 10.1186/s12891-016-0941-y.
PMID: 26868015DERIVEDRotterud JH, Reinholt FP, Beckstrom KJ, Risberg MA, Aroen A. Relationship between CTX-II and patient characteristics, patient-reported outcome, muscle strength, and rehabilitation in patients with a focal cartilage lesion of the knee: a prospective exploratory cohort study of 48 patients. BMC Musculoskelet Disord. 2014 Mar 24;15:99. doi: 10.1186/1471-2474-15-99.
PMID: 24661577DERIVEDWondrasch B, Aroen A, Rotterud JH, Hoysveen T, Bolstad K, Risberg MA. The feasibility of a 3-month active rehabilitation program for patients with knee full-thickness articular cartilage lesions: the Oslo Cartilage Active Rehabilitation and Education Study. J Orthop Sports Phys Ther. 2013 May;43(5):310-24. doi: 10.2519/jospt.2013.4354. Epub 2013 Mar 13.
PMID: 23485794DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lars Engebretsen, MD,PhD
Professor
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
April 17, 2009
First Posted
April 22, 2009
Study Start
April 1, 2009
Primary Completion
July 1, 2011
Study Completion
July 1, 2018
Last Updated
October 15, 2015
Record last verified: 2015-10